Strategic Alliance Formed to Fight Counterfeit Drugs

             Strategic Alliance Formed to Fight Counterfeit Drugs

  PR Newswire

  WASHINGTON, Oct. 29, 2013

-- The Global Pharma Health Fund and the Center for Pharmaceutical Advancement
and Training sign an agreement to improve access to high quality, safe and
beneficial medicines.

-- The partnership will strengthen human resource capacity to conduct quality
control testing to detect substandard and counterfeit medications in Africa.

WASHINGTON, Oct. 29, 2013 /PRNewswire/ --A new partnership to improve access
to high quality, safe and beneficial medicines was formalized today between
the Global Pharma Health Fund (GPHF), a charitable organization initiated and
funded exclusively by donations from Merck KGaA, Darmstadt, Germany, and the
Center for Pharmaceutical Advancement and Training (CePAT) in Ghana, a
facility established by the U.S. Pharmacopeial Convention (USP) to help build
local and regional capacity in pharmaceutical quality assurance and quality
control.

"CePAT is one of the most important initiatives to ever be implemented in this
part of the world, as it goes deep into the root problem of lack of quality
medicines in Africa, which is insufficient human resource capacity," said Dr.
Stephen K. Opuni, CEO of the Ghana Food and Drugs Authority.

"We at GPHF are excited about this opportunity to partner with CePAT on this
important initiative to combat the scourge of counterfeit drugs. Substandard
and fake medicines pose a true public health threat," said Frank Gotthardt,
Chairman of the Global Pharma Health Fund.

Counterfeit medications are a major challenge in developing countries, where
there are limited resources for screening and quality assurance.

The collaboration between CePAT and GPHF outlines a strong plan to improve
local capacity to detect substandard and counterfeit drugs through training at
CePAT's facility in Ghana and the use of the GPHF-Minilab®, a mobile
mini-laboratory for rapid drug quality verification and counterfeit medicines
detection.

Both the GPHF and CePAT believe that this strengthened cooperation will
contribute to realizing their common vision, which is of a world in which all
citizens have access to high quality, safe and beneficial medicines.

A memorandum of understanding formalizing the alliance will besigned today
during a ceremony hosted by the H.E. Peter Ammon, the German Ambassador to the
United States, at his residence in Washington, DC.

About the Global Pharma Health Fund (GPHF) The Global Pharma Health Fund
(GPHF) is a charitable organization initiated and funded exclusively by
donations from Merck KGaA, Darmstadt, Germany. Within international
development assistance initiatives, GPHF aims to improve health care and
medicines supply, the work currently supporting the fight against counterfeit
and substandard quality medicines proliferation using GPHF-Minilab® test kits.
The GPHF-Minilab® is a mobile mini-laboratory that helps in the detection of
counterfeit medicines. It enables health facilities responsible for drug
purchase, storage and distribution to protect themselves and patients against
the danger of counterfeit medicines consumption. To date, 600 Minilabs have
been supplied to health facilities across 80 countries. For more information,
visit www.gphf.org .

About the Center for Pharmaceutical Advancement and Training (CePAT) The
Center for Pharmaceutical Advancement and Training (CePAT) in Accra, Ghana,
was established by the U.S. Pharmacopeial Convention (USP) to help build human
resource capacity in pharmaceutical quality assurance and quality control by
training local professionals to serve as technical experts. Provided under
USP's Global Health Impact Programs (GHIP), CePAT delivers an integrated
platform of training, laboratory services and consulting services to support
and strengthen quality assurance systems in a sustainable way in countries in
Sub-Saharan Africa. For more information visit: http://uspgo.to/CePAT-program
.

Website: http://www.gphf.org
Contact: Frank Gotthardt, GPHF, +49-6151-72-3386,
frank.gotthardt@merckgroup.com; or Claudia Costabile, USP, +1-301-816-8314 ,
cac@usp.org